This biotechnology company utilizes pharmacogenomics and precise detection methods to create personalized prescription medications tailored to individual genetic profiles. By offering affordable genetic products, the company enables patients to enhance their health outcomes through targeted therapies.
Funding
$550K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
PVFounders
Product
Problem
Current medication prescription methods often involve a trial-and-error approach due to individual differences in drug metabolism, leading to ineffective treatments or adverse side effects in a significant percentage of patients. This results in a substantial burden on the healthcare system and increased healthcare costs.
Solution
Gene S provides a pharmacogenomics (PGx) platform called Rosa, which uses Next Generation Sequencing (NGS) and advanced analytics to deliver personalized medication recommendations. The platform analyzes a patient's genetic profile from a blood, saliva, or buccal swab sample to predict their response to specific medications. This enables healthcare providers to prescribe the most effective medications with the lowest risk of adverse reactions, optimizing patient care and potentially reducing healthcare costs. The initial focus of Rosa is on medications for mental health conditions, with plans to expand into pain management, cardiac conditions, and anesthesia.
Target Audience
The primary customers are pathology laboratories seeking to offer advanced PGx testing services, as well as doctors and other healthcare professionals looking to improve medication management for their patients.
Features
- Rosa PGx platform utilizes Next Generation Sequencing (NGS) for comprehensive genetic analysis.
- Identifies clinically relevant genetic variants, including copy number and structural variants.
- Advanced analytics software provides clinical guidelines for medications based on the patient's genetic profile.
- Streamlined workflow integrates into existing laboratory processes with minimal setup.
- Accepts DNA samples from blood, saliva, or buccal swabs.
- Delivers PGx reports to healthcare providers within days.
- Initial focus on medications for mental health conditions (RosaMind), with future applications for pain, cardiac conditions, and anesthesia.
- Designed to minimize plastic waste and reduce DNA sample quantities for cost-effectiveness.